iTeos Therapeutics, Inc.
ITOS
$10.13
$0.000.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -202.41M | -130.81M | -134.41M | -121.25M | -108.14M |
| Total Depreciation and Amortization | 1.29M | 1.26M | 1.24M | 1.14M | 1.07M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 15.03M | 17.05M | 16.35M | 20.87M | 19.20M |
| Change in Net Operating Assets | 78.03M | 12.96M | 18.65M | -18.20M | -26.11M |
| Cash from Operations | -108.06M | -99.55M | -98.18M | -117.44M | -113.98M |
| Capital Expenditure | -630.00K | -789.00K | -1.63M | -2.88M | -3.53M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 57.40M | -13.07M | -129.52M | -80.34M | 34.51M |
| Cash from Investing | 56.77M | -13.86M | -131.15M | -83.21M | 30.97M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4.85M | 122.73M | 122.72M | 122.75M | 122.72M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -477.00K | -477.00K | -477.00K | -488.00K | -- |
| Cash from Financing | 4.37M | 122.25M | 122.24M | 122.26M | 122.72M |
| Foreign Exchange rate Adjustments | 3.66M | 1.08M | -1.93M | -1.96M | -4.79M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -43.26M | 9.93M | -109.02M | -80.35M | 34.92M |